儿童新型冠状病毒肺炎诊疗和预防相关问题专家共识（第二版简化版）
Updated diagnosis, treatment and prevention of COVID-19 in children: experts' consensus statement (condensed version of the second edition).
机构信息
China National Clinical Research Center for Respiratory Diseases, Department of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Institute of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
出版信息
World J Pediatr. 2020 Jun;16(3):232-239. doi: 10.1007/s12519-020-00362-4. Epub 2020 Apr 24.
Abstract
In the early February, 2020, we called up an experts' committee with more than 30 Chinese experts from 11 national medical academic organizations to formulate the first edition of consensus statement on diagnosis, treatment and prevention of coronavirus disease 2019 (COVID-19) in children, which has been published in this journal. With accumulated experiences in the diagnosis and treatment of COVID-19 in children, we have updated the consensus statement and released the second edition recently. The current version in English is a condensed version of the second edition of consensus statement on diagnosis, treatment and prevention of COVID-19 in children. In the current version, diagnosis and treatement criteria have been optimized, and early identification of severe and critical cases is highlighted. The early warning indicators for severe pediatric cases have been summarized which is utmost important for clinical practice. This version of experts consensus will be valuable for better prevention, diagnosis and treatment of COVID-19 in children worldwide.
摘要
2020 年 2 月初，我们召集了一个由来自 11 个国家医学学术组织的 30 多名中国专家组成的专家委员会，制定了《儿童 2019 冠状病毒病（COVID-19）诊断、治疗和预防专家共识（第一版）》，并发表在本刊上。随着在儿童 COVID-19 诊治方面经验的积累，我们对共识进行了更新，并于近期发布了第二版。当前的英文版本是儿童 COVID-19 诊断、治疗和预防第二版共识的浓缩版。在当前版本中，优化了诊断和治疗标准，并强调了重症和危重症病例的早期识别。总结了重症儿科病例的早期预警指标，这对临床实践非常重要。本版专家共识将对全球儿童 COVID-19 的更好预防、诊断和治疗具有重要价值。
相似文献
1
Updated diagnosis, treatment and prevention of COVID-19 in children: experts' consensus statement (condensed version of the second edition).儿童新型冠状病毒肺炎诊疗和预防相关问题专家共识（第二版简化版）
World J Pediatr. 2020 Jun;16(3):232-239. doi: 10.1007/s12519-020-00362-4. Epub 2020 Apr 24.
2
[Chinese experts' consensus on diagnosis and treatment of severe and critical coronavirus disease 2019 (revised edition)].《新型冠状病毒肺炎重型、危重型病例诊疗中国专家共识（修订版）》
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):269-274. doi: 10.3760/cma.j.cn121430-20200218-00188.
3
Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement.儿童 2019 年新型冠状病毒感染的诊断、治疗和预防：专家共识。
World J Pediatr. 2020 Jun;16(3):223-231. doi: 10.1007/s12519-020-00343-7. Epub 2020 Feb 7.
4
[Discussion and suggestion on the classification of severe and critical coronavirus disease 2019 in Chinese experts' consensus on diagnosis and treatment of severe and critical coronavirus disease 2019].《新型冠状病毒肺炎重型、危重型病例分类的讨论与建议——新型冠状病毒肺炎重型、危重型病例诊疗中国专家共识》
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):277. doi: 10.3760/cma.j.cn121430-20200226-00339.
5
Clinical practice guidelines and experts' consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review.临床实践指南和传统中药专家共识治疗新型冠状病毒（COVID-19）：系统评价方案。
Syst Rev. 2020 Aug 3;9(1):170. doi: 10.1186/s13643-020-01432-4.
6
Imaging of coronavirus disease 2019: A Chinese expert consensus statement.2019 冠状病毒病影像学表现：中国专家共识。
Eur J Radiol. 2020 Jun;127:109008. doi: 10.1016/j.ejrad.2020.109008. Epub 2020 Apr 18.
7
Treatment of children with COVID-19: position paper of the Italian Society of Pediatric Infectious Disease.儿童 COVID-19 治疗：意大利儿科传染病学会立场文件。
Ital J Pediatr. 2020 Sep 24;46(1):139. doi: 10.1186/s13052-020-00900-w.
8
Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version).《COVID-19 的化学预防、诊断、治疗和出院管理：基于证据的临床实践指南（更新版）》
Mil Med Res. 2020 Sep 4;7(1):41. doi: 10.1186/s40779-020-00270-8.
9
Clinical Practice Guidelines and Experts' Consensuses for Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Chinese Herbal Medicine: A Systematic Review.《2019冠状病毒病（COVID-19）患者中药治疗临床实践指南与专家共识：一项系统评价》
Chin J Integr Med. 2020 Oct;26(10):786-793. doi: 10.1007/s11655-020-3431-x. Epub 2020 Oct 8.
10
[Expert consensus on prevention and treatment strategies for osteonecrosis of femoral head during the prevention and control of novel coronavirus pneumonia (2020)].新型冠状病毒肺炎防控期间股骨头坏死防治策略专家共识（2020年）
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020 Aug 15;34(8):1031-1035. doi: 10.7507/1002-1892.202003068.
引用本文的文献
1
Changes in metrics of continuous glucose monitoring during COVID-19 in Korean children and adolescents with type 1 diabetes mellitus.韩国1型糖尿病儿童和青少年在新冠疫情期间连续血糖监测指标的变化
Ann Pediatr Endocrinol Metab. 2025 Feb;30(1):38-44. doi: 10.6065/apem.2448036.018. Epub 2025 Feb 28.
2
Association of ACE1 I/D polymorphism and susceptibility to COVID-19 in Egyptian children and adolescents.ACE1 I/D 多态性与埃及儿童和青少年 COVID-19 易感性的关联。
Pediatr Res. 2024 Oct;96(5):1347-1354. doi: 10.1038/s41390-023-02982-8. Epub 2024 Jan 4.
3
T Lymphocyte Characteristic Changes Under Serum Cytokine Deviations and Prognostic Factors of COVID-19 in Pregnant Women.血清细胞因子偏差下 T 淋巴细胞特征变化与 COVID-19 孕妇的预后因素。
Appl Biochem Biotechnol. 2024 Jul;196(7):4366-4381. doi: 10.1007/s12010-023-04775-5. Epub 2023 Nov 10.
4
Chinese herbal medicine and COVID-19: quality evaluation of clinical guidelines and expert consensus and analysis of key recommendations.中药与新型冠状病毒肺炎：临床指南与专家共识的质量评估及关键建议分析
Acupunct Herb Med. 2022 Sep;2(3):152-161. doi: 10.1097/HM9.0000000000000043. Epub 2022 Dec 8.
5
Associations between ongoing COVID-19 lockdown and the financial and mental health experiences of Australian families.持续的新冠疫情封锁与澳大利亚家庭的经济和心理健康状况之间的关联。
Aust J Soc Issues. 2022 Dec 26. doi: 10.1002/ajs4.252.
6
Primary care is the ideal setting to promote COVID-19 vaccination for children.初级保健是促进儿童接种新冠疫苗的理想场所。
Med J Aust. 2022 Dec 12;217(11):575-577. doi: 10.5694/mja2.51769. Epub 2022 Nov 20.
7
Impact of COVID-19 in Children with Chronic Lung Diseases.COVID-19 对慢性肺部疾病患儿的影响。
Int J Environ Res Public Health. 2022 Sep 13;19(18):11483. doi: 10.3390/ijerph191811483.
8
Analysis of Convalescent Plasma Transfusion in Children Confirmed with COVID-19: A Systemic Review.新冠病毒肺炎确诊儿童恢复期血浆输注的分析：一项系统评价
Florence Nightingale J Nurs. 2022 Oct;30(3):301-309. doi: 10.5152/FNJN.2022.21260.
9
COVID-19 in Hospitalised Children and Adolescents: Review of the First Pandemic Year at Vilnius University Hospital Santaros Klinikos.住院儿童和青少年中的新冠病毒肺炎：维尔纽斯大学医院圣塔罗斯临床医院大流行第一年回顾
Acta Med Litu. 2022;29(1):44-50. doi: 10.15388/Amed.2021.29.1.8. Epub 2022 Jul 26.
10
Evolving operational guidance and experiences for radiology and nuclear medicine facilities in response to and beyond the COVID-19 pandemic.针对 COVID-19 大流行及之后的情况，不断演变的放射科和核医学设施的操作指南和经验。
Br J Radiol. 2022 Sep 1;95(1138):20200511. doi: 10.1259/bjr.20200511. Epub 2022 Aug 5.
本文引用的文献
1
SARS-CoV-2 Infection in Children.儿童感染新型冠状病毒2型
N Engl J Med. 2020 Apr 23;382(17):1663-1665. doi: 10.1056/NEJMc2005073. Epub 2020 Mar 18.
2
Back to the spring of 2020: facts and hope of COVID-19 outbreak.回到2020年春天：新冠疫情的事实与希望。
Front Med. 2020 Apr;14(2):113-116. doi: 10.1007/s11684-020-0758-9. Epub 2020 Mar 14.
3
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
4
[The way to reduce the"false negative results"of 2019 novel coronavirus nucleic acid detection].[降低2019新型冠状病毒核酸检测“假阴性结果”的方法]
Zhonghua Yi Xue Za Zhi. 2020 Feb 19;100(0):E008. doi: 10.3760/cma.j.issn.0376-2491.2020.0008.
5
Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement.儿童 2019 年新型冠状病毒感染的诊断、治疗和预防：专家共识。
World J Pediatr. 2020 Jun;16(3):223-231. doi: 10.1007/s12519-020-00343-7. Epub 2020 Feb 7.
6
Global virus outbreaks: Interferons as 1st responders.全球病毒爆发：干扰素作为第一反应者。
Semin Immunol. 2019 Jun;43:101300. doi: 10.1016/j.smim.2019.101300.
7
[Expert consensus on diagnosis and treatment of herpangina (version 2019)].《疱疹性咽峡炎诊断与治疗专家共识（2019版）》
Zhonghua Er Ke Za Zhi. 2019 Mar 2;57(3):177-180. doi: 10.3760/cma.j.issn.0578-1310.2019.03.004.
8
Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy.I 型干扰素在婴儿期增强呼吸道合胞病毒感染的 IgA 免疫。
Sci Rep. 2018 Jul 23;8(1):11034. doi: 10.1038/s41598-018-29456-w.
9
[Recombinant human interferon alpha 2b broad-spectrum anti-respiratory viruses pharmacodynamics study in vitro].重组人干扰素α2b体外抗呼吸道病毒广谱药效学研究
Yao Xue Xue Bao. 2014 Nov;49(11):1547-53.
10
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study.利巴韦林与干扰素治疗中东呼吸综合征冠状病毒感染患者的一项观察性研究。
Int J Infect Dis. 2014 Mar;20:42-6. doi: 10.1016/j.ijid.2013.12.003. Epub 2014 Jan 6.
Zotero 插件